Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor-Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies. [electronic resource]
Producer: 20200207Description: 764-770 p. digitalISSN:- 1523-6536
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Busulfan -- pharmacology
- Cord Blood Stem Cell Transplantation -- methods
- Cytarabine -- pharmacology
- Female
- Granulocyte Colony-Stimulating Factor -- pharmacology
- Humans
- Male
- Middle Aged
- Myeloablative Agonists -- pharmacology
- Myelodysplastic Syndromes -- drug therapy
- Vidarabine -- analogs & derivatives
- Whole-Body Irradiation -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.